SION NASDAQ
Sionna Therapeutics, Inc.
1W: -2.4%
1M: -3.4%
3M: +17.6%
YTD: +6.5%
1Y: +198.0%
$41.13
-0.62 (-1.49%)
Weekly Expected Move ±10.8%
$32
$36
$40
$45
$49
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026130
Institutions Holding
+22 vs prior
88.2%
Ownership
-7.28%
29
New
35
Increased
49
Reduced
22
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | OrbiMed Capital GP VIII LLC | director | S-Sale | 184,639 | $46.22 | $8.5M | Filing |
| 2026-05-11 | ORBIMED ADVISORS LLC | director | S-Sale | 184,639 | $46.22 | $8.5M | Filing |
| 2026-05-11 | Thompson Peter A. | director | S-Sale | 184,639 | $46.22 | $8.5M | Filing |
| 2026-05-08 | OrbiMed Capital GP VIII LLC | director | S-Sale | 59,767 | $44.58 | $2.7M | Filing |
| 2026-05-08 | ORBIMED ADVISORS LLC | director | S-Sale | 59,767 | $44.58 | $2.7M | Filing |
| 2026-05-08 | Thompson Peter A. | director | S-Sale | 59,767 | $44.58 | $2.7M | Filing |
| 2026-05-07 | OrbiMed Capital GP VIII LLC | director | S-Sale | 48,546 | $44.61 | $2.2M | Filing |
| 2026-05-07 | ORBIMED ADVISORS LLC | director | S-Sale | 48,546 | $44.61 | $2.2M | Filing |
| 2026-05-07 | Thompson Peter A. | director | S-Sale | 48,546 | $44.61 | $2.2M | Filing |
| 2026-04-18 | OrbiMed Capital GP VIII LLC | director | S-Sale | 2,948 | $44.52 | $131K | Filing |
| 2026-04-18 | ORBIMED ADVISORS LLC | director | S-Sale | 2,948 | $44.52 | $131K | Filing |
| 2026-04-18 | Thompson Peter A. | director | S-Sale | 2,948 | $44.52 | $131K | Filing |
| 2026-04-17 | ORBIMED ADVISORS LLC | director | S-Sale | 52,397 | $44.68 | $2.3M | Filing |
| 2026-04-17 | OrbiMed Capital GP VIII LLC | director | S-Sale | 52,397 | $44.68 | $2.3M | Filing |
| 2026-04-17 | Thompson Peter A. | director | S-Sale | 52,397 | $44.68 | $2.3M | Filing |
| 2026-04-16 | OrbiMed Capital GP VIII LLC | director | S-Sale | 226,906 | $45.34 | $10.3M | Filing |
| 2026-04-16 | ORBIMED ADVISORS LLC | director | S-Sale | 226,906 | $45.34 | $10.3M | Filing |
| 2026-04-16 | Thompson Peter A. | director | S-Sale | 226,906 | $45.34 | $10.3M | Filing |
| 2026-04-15 | Thompson Peter A. | director | S-Sale | 235,863 | $44.64 | $10.5M | Filing |
| 2026-04-15 | OrbiMed Capital GP VIII LLC | director | S-Sale | 235,863 | $44.64 | $10.5M | Filing |
| 2026-04-15 | ORBIMED ADVISORS LLC | director | S-Sale | 235,863 | $44.64 | $10.5M | Filing |
| 2026-04-14 | OrbiMed Capital GP VIII LLC | director | S-Sale | 47,814 | $44.51 | $2.1M | Filing |
| 2026-04-14 | ORBIMED ADVISORS LLC | director | S-Sale | 47,814 | $44.51 | $2.1M | Filing |
| 2026-04-14 | Thompson Peter A. | director | S-Sale | 47,814 | $44.51 | $2.1M | Filing |
| 2026-03-05 | Fitzpatrick Jennifer | officer: chief legal officer | S-Sale | 10,250 | $33.86 | $347K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9,905,045 | $397M | — | 2026-03-31 | Filing |
| TPG GP A, LLC | 6,494,962 | $260M | -250,000 | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 3,530,702 | $142M | -30,953 | 2026-03-31 | Filing |
| VIKING GLOBAL INVESTORS LP | 3,195,181 | $128M | — | 2026-03-31 | Filing |
| Atlas Venture Life Science Advisors, LLC | 2,995,602 | $120M | — | 2026-03-31 | Filing |
| ENAVATE SCIENCES GP, LLC | 2,478,030 | $99M | — | 2026-03-31 | Filing |
| JENNISON ASSOCIATES LLC | 1,451,220 | $58M | +335,942 | 2026-03-31 | Filing |
| JPMORGAN CHASE & CO | 1,465,014 | $54M | +233,195 | 2026-03-31 | Filing |
| BlackRock, Inc. | 1,295,867 | $52M | +4,268 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,029,497 | $41M | +1,029,497 | 2026-03-31 | Filing |
| STATE STREET CORP | 756,227 | $30M | +62,832 | 2026-03-31 | Filing |
| EVENTIDE ASSET MANAGEMENT, LLC | 645,530 | $26M | +6,485 | 2026-03-31 | Filing |
| Aberdeen Group plc | 564,175 | $23M | -275,785 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 389,872 | $16M | +9,830 | 2026-03-31 | Filing |
| Siren, L.L.C. | 300,000 | $12M | — | 2026-03-31 | Filing |
| Sio Capital Management, LLC | 294,340 | $12M | +294,340 | 2026-03-31 | Filing |
| Soleus Capital Management, L.P. | 293,500 | $12M | +25,000 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 263,174 | $11M | +226,905 | 2026-03-31 | Filing |
| Ensign Peak Advisors, Inc | 255,636 | $10M | +175,774 | 2026-03-31 | Filing |
| Candriam S.C.A. | 236,813 | $9M | +236,813 | 2026-03-31 | Filing |